Non-Hodgkin's lymphoma and chronic lymphocytic leukaemia Pharmacy Europe Treanda is approved in patients with chronic lymphocytic leukaemia (CLL) who have received no prior treatment and in patients with relapsed indolent B-cell non-Hodgkin's lymphoma (iNHL) who did not respond to treatment with a rituximab regimen or where ... |
